Enzymatica, a swedish firm has carried a study that showed positive results against the covid virus. In the company’s press release they stated ““The goal of the present study was to determine the ability of ColdZyme to deactivate SARS-CoV-2 known to cause the Covid-19 pandemic. A virucidal efficacy suspension test was conducted using ColdZyme against SARS-CoV-2. ColdZyme deactivated SARS-CoV-2 by 98.3 per cent (1.76 log10) in 20 minutes.”
They continued to drive the importance of the new spray by saying “Thus, the results indicate that ColdZyme can offer a protective barrier against SARS-CoV-2,” said Claus Egstrand, The stock in the company jumped with the release of the news about the new spray.